(2.6%) and continuous renal replacement therapy (CRRT) (2.3%). 6 Renal transplantation is very high cost and only available in few centers in Indonesia, that are nephrology units in university hospitals. A recent issue of organ trade or trafficking is an ethical and legal problem that inhibit the development of renal transplantation in some countries. Organ transplantation is an effective therapy for end-stage organ failure and is widely practiced around the world. According to WHO, kidney transplants are carried out in 91 countries. Around 66 000 kidney transplants were performed globally in 2005. The access of patients to organ transplantation, however, varies according to their national situations and is partly determined by the cost of health care, the level of technical capacity and, most importantly, the availability of organs. 7 Supported by this reality, a significant organ market has developed; the World Health Organization estimates that 5%-10% of the nearly 70,000 kidneys transplanted annually are obtained by organ trafficking. 8 The future burden of CKD predicted to be higher over next decade. A research in the United States had a result for US adults aged 30 to 49, 50 to 64, and 65 years or older with no CKD at baseline, the residual lifetime incidences of CKD are 54%, 52%, and 42%, respectively. The prevalence of CKD in adults 30 years or older is projected to increase from 13.2% currently to 14.4% in 2020 and 16.7% in 2030. For an individual, the lifetime risk of CKD is high, with more than half the US adults aged 30 to 64 years likely to develop CKD. Knowing the lifetime incidence of CKD may raise individuals' awareness and encourage them to take steps to prevent CKD. From a national burden perspective, the research estimate that the population prevalence of CKD will increase in coming decades, suggesting that development of interventions to slow CKD onset and progression should be considered. 9 The take home messages from those researchers emphasize us to be aware of acute kidney injury and chronic kidney disease. We, as a health practitioner, should perform screening to individuals with risk factors for developing CKD at least with tools like detecting proteinuria and erythrocyte sediment in urine standard dipstick or microscopic examination, check the level of serum creatinine and glomerular filtration rate yearly. After early detection, the patients with CKD should receive the best management to avoid progressivity of CKD and ESRD from physician or nephrologist. Glomerulonephritis and diabetic nephropathy as the first and second etiology of ESRD should be treated appropriately. In the other hand, we also have the responsibility to promote healthy lifestyle and avoid nephrotoxic drugs, herbs or substances to all healthy people surrounding us. We have to do renal replacement treatment for ESRD in the best way according to ethical and legal concern.
